FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for propafenone hydrochloride from Rising Pharma Holdings, providing a generic version of the antiarrhythmic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Paroxysmal Supraventricular Tachycardia
• Ventricular Tachycardia

Drugs mentioned

• Propafenone hydrochloride (Propafenone hydrochloride)

Snippet

SUPPL AP for PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)